Approved and experimental small‐molecule oncology kinase inhibitor drugs: a mid‐2016 overview
PM Fischer - Medicinal research reviews, 2017 - Wiley Online Library
Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and
pharmacology and the first small‐molecule kinase inhibitor, imatinib, was approved for …
pharmacology and the first small‐molecule kinase inhibitor, imatinib, was approved for …
Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.
PM Fischer - Medicinal Research Reviews, 2017 - search.ebscohost.com
Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview
PM Fischer - Medicinal research reviews, 2017 - pubmed.ncbi.nlm.nih.gov
Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
[PDF][PDF] Approved and experimental small-molecule oncology kinase inhibitor drugs: a mid-2016 overview
PM Fischer - core.ac.uk
Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.
PM Fischer - Medicinal Research Reviews, 2016 - europepmc.org
Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
Approved and experimental small-molecule oncology kinase inhibitor drugs: a mid-2016 overview
PM Fischer - Medicinal Research Reviews - nottingham-repository.worktribe.com
Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
Approved and Experimental Small‐Molecule Oncology Kinase Inhibitor Drugs: A Mid‐2016 Overview
PM Fischer - Medicinal Research Reviews, 2017 - infona.pl
Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and
pharmacology and the first small‐molecule kinase inhibitor, imatinib, was approved for …
pharmacology and the first small‐molecule kinase inhibitor, imatinib, was approved for …
Approved and experimental small-molecule oncology kinase inhibitor drugs: a mid-2016 overview
PM Fischer - Medicinal Research Reviews - eprints.nottingham.ac.uk
Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
[PDF][PDF] Approved and experimental small-molecule oncology kinase inhibitor drugs: a mid-2016 overview
PM Fischer - nottingham-repository.worktribe.com
Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
[PDF][PDF] Approved and experimental small-molecule oncology kinase inhibitor drugs: a mid-2016 overview
PM Fischer - core.ac.uk
Kinase inhibitor research is a comparatively recent branch of medicinal chemistry and
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …
pharmacology and the first small-molecule kinase inhibitor, imatinib, was approved for …